Mutations found in Australian women with a strong history of breast and ovarian cancer but not BRCA1 or BRCA2 mutation (Li et al, 2021) are located in the MM1 domain, and appear essential for FANCF binding. This evidence concerns the gene BRCA1 and ovarian carcinoma.